The conventions are over, and the general-election campaign is officially on. While reproductive health is sure to play a key role in the race between Vice President Kamala Harris and former President Donald Trump, it’s less clear what role other health issues will play. Meanwhile, Medicare recently announced negotiated prices of the first 10 drugs selected under the 2022 Inflation Reduction Act.
The announcement is boosting attention to what was already a major pocketbook issue for both Republicans and Democrats. This week’s panelists are Julie Rovner of KFF Health News, Joanne Kenen of Politico and Johns Hopkins University’s schools of nursing and public health, Shefali Luthra of The 19 , and Alice Miranda Ollstein of Politico. Among the takeaways from this week’s episode: Also this week, Rovner interviews KFF Health News’ Tony Leys, who reported and wrote the latest KFF Health News-NPR “ ” installment about a woman who fought back after being charged for two surgeries despite undergoing only one.
Do you have a confusing or outrageous medical bill you want to share? ! Subscribe to KFF Health News' free Morning Briefing. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too: The New York Times’ “ ,” by Emily Baumgaertner. The Milwaukee Journal Sentinel’s “ ” by Natalie Eilbert.
The Wall Street Journal’s “ ,” by Theo Francis and Melanie Evans. The Washington Post’s “ ,” by Ariana Eunjung Cha..
